Ironwood Pharmaceuticals | IRWD - Коммерческие и административные расходы





Коммерческие и административные расходы Изменить Дата
Acadia Pharmaceuticals USD 146.88M 1.69M 2026-09
Agios Pharmaceuticals USD 51.55M 13.09M 2026-06
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Almirall -29.5M 4.72M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 101.44M 827K 2026-06
Astellas Pharma JPY 215.29B 225M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Charles River Laboratories USD 140.59M 88.31M 2026-09
Coherus Biosciences USD 15M 6.26M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Halozyme Therapeutics USD 58.24M 1.24M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
MacroGenics USD 7.9M 1.81M 2026-06
Moderna USD 282M 66M 2026-09
Myriad Genetics USD 122.3M 6.7M 2025-12
Pacira USD 950.8M 858.99M 2026-09
PTC Therapeutics USD 80.63M 6.74M 2026-06
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sarepta Therapeutics USD 118.61M 11.01M 2026-09
Takeda JPY 271.71B 14.8B 2026-09
Ultragenyx Pharmaceutical USD 97M 9M 2026-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12